arrow
R

Raphaël Helaers

universite catholique louvain
H指数:21
被引数:2,230

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of the tumor immune contexture in microsatellite-stable metastatic colorectal cancer treated with avelumab, cetuximab, and irinotecan

微卫星稳定型转移性结直肠癌接受阿维鲁姆单抗、西妥昔单抗和伊立替康治疗后,肿瘤免疫微环境的影响

2025-06-240
OAAI
PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma

PPARα介导的脂质代谢重编程支持头颈部鳞状细胞癌中抗EGFR疗法的耐药性。

2025-02-010
OA
Tumor-agnostic plasma assay for circulating tumor DNA detects minimal residual disease and predicts outcome in locally advanced squamous cell carcinoma of the head and neck

循环肿瘤DNA的肿瘤不可知血浆测定可检测微小残留疾病并预测头颈部局部晚期鳞状细胞癌的预后

2023-12-0115
OA
Tumour-agnostic plasma assay for circulating tumour DNA predicts outcome in recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with a PD-1 inhibitor

循环肿瘤DNA的肿瘤不可知血浆测定可预测用PD-1抑制剂治疗的头颈部复发和/或转移性鳞状细胞癌的结果

2023-12-010
PRE
Minimal residual disease (MRD) diagnosed by a plasma tumor-agnostic circulating tumor DNA (ctDNA) assay after curative therapy in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN) predicts disease relapse and survival
2023-10-010
OA
Pathogenic variants in MDFIC cause recessive central conducting lymphatic anomaly with lymphedema
2022-03-0221
PRE
Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families

肿瘤测序可用于完善无法解释的高风险乳腺癌家族中种系变异的分析

2020-04-157
OAAI